Align Technology (ALGN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Q3 2024 revenues reached $977.9 million, up 1.8% year-over-year but down 4.9% sequentially, with strong international and Systems and Services growth offset by U.S. market weakness and seasonality.
Clear Aligner volumes grew 2.5% year-over-year to 617,220 cases, with notable strength in APAC, EMEA, and Latin America, and teen volume up 6.7%.
Systems and Services segment delivered 15.6% year-over-year revenue growth, driven by higher scanner ASPs, new product adoption, and increased leasing/rental activity.
Announced restructuring actions, including a reduction of approximately 700 positions and executive changes, to align with market conditions and support future technology investments and margin expansion.
Net income for Q3 2024 was $116.0 million ($1.55 per diluted share GAAP; $2.35 non-GAAP), with cash and cash equivalents at $1.041 billion.
Financial highlights
Q3 2024 total revenues: $977.9 million (+1.8% Y/Y, -4.9% Q/Q); Clear Aligner revenues: $786.8 million (-1.0% Y/Y, -5.4% Q/Q); Systems and Services revenues: $191.0 million (+15.6% Y/Y, -2.9% Q/Q).
Gross margin was 69.7% (up 0.7 pts Y/Y); Clear Aligner gross margin: 70.3%; Systems and Services: 67.5%.
GAAP operating margin was 16.6% (down 0.7 pts Y/Y); non-GAAP operating margin was 22.1% (up 0.3 pts Y/Y).
Net income for Q3 2024: $116.0 million (down from $121.4 million in Q3 2023); diluted EPS: $1.55 (GAAP), $2.35 (non-GAAP).
Free cash flow for Q3 was $233.9 million; cash and equivalents at quarter-end: $1.041 billion.
Outlook and guidance
Q4 2024 revenues expected between $995 million and $1.015 billion.
Q4 Clear Aligner volume and ASPs expected to be slightly up sequentially; Systems and Services revenues to rise with typical seasonality.
Q4 GAAP operating margin projected slightly below 14% due to restructuring charges; non-GAAP margin expected to be slightly up sequentially.
Capital expenditures for 2024 anticipated to exceed $100 million, focused on manufacturing and facility investments.
Restructuring actions are expected to drive margin accretion in 2025.
Latest events from Align Technology
- Broad-based growth, strong DSO performance, and stable outlook drive confidence for 2026.ALGN
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Strong growth in Europe and APAC, with product innovation and efficiency boosting margins.ALGN
Leerink Global Healthcare Conference 202610 Mar 2026 - Record Q4 and FY2025 results, robust Clear Aligner growth, and strong 2026 outlook.ALGN
Q4 20254 Feb 2026 - Digital dentistry expansion, AI-driven innovation, and global growth drive strong financial outlook.ALGN
Investor Day 20253 Feb 2026 - Q2 2024 revenue up 2.6% to $1.03B; margin pressured by FX, mix, and legal settlement.ALGN
Q2 20243 Feb 2026 - Q1 2024 growth fueled by AI, 3D printing, and new digital orthodontic products.ALGN
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Raised guidance and new products drive growth, margin expansion, and digital adoption.ALGN
Jefferies Global Healthcare Conference31 Jan 2026 - Stable market, teen growth, new products, and flexible strategies drive future expansion.ALGN
Baird's 2024 Global Healthcare Conference21 Jan 2026 - Growth investments, digital innovation, and global expansion drive recovery and future margin gains.ALGN
UBS Global Healthcare Conference 202414 Jan 2026